J. C. van Denderen

发表

Differential effects of 6-OHDA lesions of the frontal cortex and caudate nucleus on the ability to acquire an attentional set.

T. Robbins, B. Everitt, J. Dalley, 2001, Cerebral cortex.

Bone formation rather than inflammation reflects Ankylosing Spondylitis activity on PET-CT: a pilot study

R. Boellaard, B. Dijkmans, O. Hoekstra, 2012, Arthritis Research & Therapy.

Decreased clinical response to adalimumab in ankylosing spondylitis is associated with antibody formation

B. Dijkmans, L. Aarden, G. Wolbink, 2009, Annals of the rheumatic diseases.

Prevalence of Chlamydia trachomatis in urine of male patients with ankylosing spondylitis is not increased

B. Dijkmans, P. Bezemer, S. Morré, 2000, Annals of the rheumatic diseases.

Statin therapy might be beneficial for patients with ankylosing spondylitis

B. Dijkmans, M. Nurmohamed, J. C. van Denderen, 2005, Annals of the rheumatic diseases.

Immunogenicity does not influence treatment with etanercept in patients with ankylosing spondylitis

B. Dijkmans, L. Aarden, J. C. van Denderen, 2008, Annals of the rheumatic diseases.

COBRA combination therapy in patients with early rheumatoid arthritis: long-term structural benefits of a brief intervention.

Rene Westhovens, Maarten Boers, S. van der Linden, 2002, Arthritis and rheumatism.

Adalimumab Significantly Reduces the Recurrence Rate of Anterior Uveitis in Patients with Ankylosing Spondylitis

M. Suttorp-Schulten, J. C. van Denderen, I. E. van der Horst-Bruinsma, 2014, The Journal of Rheumatology.

Double blind, randomised, placebo controlled study of leflunomide in the treatment of active ankylosing spondylitis

B. Dijkmans, J. C. van Denderen, I. E. van der Horst-Bruinsma, 2005, Annals of the rheumatic diseases.

Etanercept Increases Bone Mineral Density in Ankylosing Spondylitis, but Does Not Prevent Vertebral Fractures Etanercept Increases Bone Mineral Density in Ankylosing Spondylitis, but Does Not Prevent Vertebral Fractures Introduction

B. Dijkmans, W. Lems, J. C. van Denderen, 2022 .

Discovertebral (Andersson) lesions in severe ankylosing spondylitis: a study using MRI and conventional radiography

R. Manoliu, B. V. van Royen, J. C. van Denderen, 2010, Clinical Rheumatology.

Low bone mineral density is related to male gender and decreased functional capacity in early spondylarthropathies

B. Dijkmans, W. Lems, M. Heymans, 2010, Clinical Rheumatology.

Moving instead of asking? Performance-based tests and BASFI-questionnaire measure different aspects of physical function in ankylosing spondylitis

B. Dijkmans, J. Dekker, J. C. van Denderen, 2012, Arthritis Research & Therapy.

Decreased clinical response to infliximab in ankylosing spondylitis is correlated with anti-infliximab formation

B. Dijkmans, L. Aarden, J. C. van Denderen, 2007, Annals of the rheumatic diseases.

Increased disease activity is associated with a deteriorated lipid profile in patients with ankylosing spondylitis

B. Dijkmans, J. Twisk, M. Nurmohamed, 2006, Annals of the rheumatic diseases.

Survival, comorbidities and joint damage 11 years after the COBRA combination therapy trial in early rheumatoid arthritis

S. van der Linden, B. Dijkmans, M. Westedt, 2009, Annals of the rheumatic diseases.

Objective Evaluation of Physical Functioning after Tumor Necrosis Factor Inhibitory Therapy in Patients with Ankylosing Spondylitis: A Selection of 3 Feasible Performance-based Tests

B. Dijkmans, J. Dekker, J. C. van Denderen, 2015, The Journal of Rheumatology.

Physiological effects of exhaustive physical exercise in primary fibromyalgia syndrome (PFS): is PFS a disorder of neuroendocrine reactivity?

A P Hollander, J. Boersma, J. C. van Denderen, 1992, Scandinavian journal of rheumatology.

Fat Mass Lowers the Response to Tumor Necrosis Factor-α Blockers in Patients with Ankylosing Spondylitis

W. Lems, J. C. van Denderen, I. E. van der Horst-Bruinsma, 2017, The Journal of Rheumatology.

Two-laser dual-immunofluorescence confocal laser scanning microscopy using Cy2- and Cy5-conjugated secondary antibodies: unequivocal detection of co-localization of neuronal markers.

F. Wouterlood, J. C. van Denderen, W. Härtig, 1998, Brain research. Brain research protocols.

What do we miss? ASAS non-responders on anti-TNF therapy show improvement in performance-based physical function.

B. Dijkmans, J. Dekker, J. C. van Denderen, 2013, Rheumatology.

Long‐Term Treatment With TNF‐Alpha Inhibitors Improves Bone Mineral Density But Not Vertebral Fracture Progression in Ankylosing Spondylitis

W. Lems, J. C. van Denderen, I. E. van der Horst-Bruinsma, 2019, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Immunogenicity does not influence treatment with etanercept in patients with ankylosing spondylitis

B. Dijkmans, L. Aarden, G. Wolbink, 2009 .

Efficacy and safety of mesalazine (Salofalk) in an open study of 20 patients with ankylosing spondylitis.

B. Dijkmans, P. Bezemer, J. C. van Denderen, 2003, The Journal of rheumatology.

Etanercept Increases Bone Mineral Density in Ankylosing Spondylitis, but Does Not Prevent Vertebral Fractures: Results of a Prospective Observational Cohort Study

J. C. van Denderen, I. E. van der Horst-Bruinsma, M. Nurmohamed, 2016, The Journal of Rheumatology.